Filter by
 

Type of content

Publication date

Main subject

Main subject

Keywords

Keywords

Target audience

Series/ Type

Series/type

Search tool

Displaying 101 - 120 of 134

Publications

EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide)

01.01.2014

The EMCDDA–Europol Joint Report on new psychoactive substance AH-7921 (3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded...

Publications

EMCDDA–Europol Joint Report on a new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25I-NBOMe)

01.01.2014

The EMCDDA–Europol Joint Report on new psychoactive substance 4-iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine, commonly known by the abbreviation ‘25I-NBOMe’, submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the...

Publications

EMCDDA–Europol Joint Report on a new psychoactive substance: methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone)

01.01.2014

The EMCDDA–Europol Joint Report on new psychoactive substance methoxetamine (2-(3-methoxyphenyl)-2-(ethylamino)cyclohexanone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that...

Publications

EMCDDA–Europol Joint Report on a new psychoactive substance: MDPV (3,4-methylenedioxypyrovalerone)

01.01.2014

The EMCDDA–Europol Joint Report on new psychoactive substance MDPV (3,4-methylenedioxypyrovalerone), submitted in December 2013 to the Council of the EU, the European Commission and the EMA. After assessing the available evidence, the EMCDDA and Europol concluded that sufficient information had...

Publications

Report on the risk assessment of 4-methylamphetamine (4-MA) in the framework of the Council Decision on new psychoactive substances

01.01.2014

This report presents the data and findings of the risk assessment on the new psychoactive substance, 4-methylamphetamine, that was conducted by the Scientific Committee of the EMCDDA. Concerns over the availability and use of this stimulant drug in the European Union led to an assessment of the...

Publications

MDMA ('Ecstasy') drug profile

25.05.2013

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance, as well as analysis, physical form (e.g. powder, tablet) and mode of use...

Publications

EMCDDA–Europol 2012 Annual Report on the implementation of Council Decision 2005/387/JHA (New drugs in Europe, 2012)

01.05.2013

pThis report presents the key activities performed by the EMCDDA and Europol in 2012 and includes details of all the relevant activities in support of the implementation of Council Decision 2005/387/JHA on the information exchange, risk assessment and control of new psychoactive substances.

Publications

EU drug markets report: a strategic analysis

01.01.2013

The EU drug markets report is the first comprehensive overview of illicit drug markets in the European Union. It covers issues such as production, consumer markets, trafficking, organised crime and policy responses, along with a review of the markets for heroin, cocaine, cannabis, amphetamine,...

Publications

EMCDDA–Europol Joint Report on a new psychoactive substance: (4-MA) 4-methylamphetamine

01.11.2012

Summary: At the end of 2011 and in 2012, the EMCDDA and Europol examined the available information on a new psychoactive substance, 4-methylamphetamine (4-MA). The two organisations concluded that sufficient information had been accumulated to merit the production of a Joint Report on 4-...

Publications

EMCDDA–Europol 2011 Annual Report on the implementation of Council Decision 2005/387/JHA

01.04.2012

This report presents the results and outlines the key achievements for 2011 on the information exchange, risk-assessment and control of new psychoactive substances. New drugs were detected in the European Union in 2011 at the rate of around one per week, with a total of 49 new psychoactive...

Publications

Synthetic cathinones drug profile

08.02.2012

Drug profiles are scientifically sound descriptions of drugs in the form of ‘drug profiles’. Presented in a standardised way, each profile briefly gives the chemistry, pharmacology, synthesis and precursors of each substance, as well as analysis, physical form (e.g. powder, tablet) and mode of use...

Publications

Report on the risk assessment of mephedrone in the framework of the Council Decision on new psychoactive substances

01.05.2011

This publication presents the summary findings and the conclusions of the risk assessment on mephedrone, carried out by the EMCDDA’s extended Scientific Committee, with participation of additional experts from the European Commission, Europol and the EMA. The risk assessment report, which was...

Publications

EMCDDA–Europol 2010 Annual Report on the implementation of Council Decision 2005/387/JHA

01.05.2011

This report presents the results and outlines the key achievements for 2010 on the information exchange, risk-assessment and control of new psychoactive substances. In 2010, 41 new psychoactive substances were officially notified for the first time in the European Union through the Early-Warning...

Publications

EMCDDA–Europol 2009 Annual Report on the implementation of Council Decision 2005/387/JHA

01.05.2010

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2009. In 2009, 24 new psychoactive substances were officially notified for the first time in the European Union through the Early-Warning System (EWS). All new...

Publications

Risk assessment of new psychoactive substances — operating guidelines

01.03.2010

The principal aim of these guidelines is to put in place a sound methodological and procedural basis for carrying out each risk assessment, by using a semi-quantitative assessment procedure. This publication is a revision of the Guidelines for the risk assessment of new synthetic drugs (published...

Publications

Europol–EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone (mephedrone)

01.03.2010

In January 2010, increased evidence of the availability and use of mephedrone (4- methylmethcathinone) prompted the EMCDDA and Europol to launch a procedure for the production of a Joint Report. Pursuant to the findings of this report, the Council of the EU formally requested a risk assessment of...

Publications

Understanding the 'Spice' phenomenon

01.11.2009

Smokable herbal mixtures under the brand name ‘Spice’ are known to have been sold on the Internet and in various specialised shops since at least 2006 and anecdotal reports suggest that those products may have been available as early as 2004. Although advertised as an ‘exotic incense blend which...

Publications

EMCDDA–Europol 2008 Annual Report on the implementation of Council Decision 2005/387/JHA

01.05.2009

This report presents the results and outlines the key achievements and challenges faced by mechanism set up by the Council Decision in 2008. In 2008, 13 new psychoactive substances were officially notified for the first time in the European Union through the Early-Warning System (EWS). The number...

Publications

Legal Responses to New Psychoactive Substances in Europe

19.02.2009

This paper starts from the premise that, when a new psychoactive substance appears on the licit/illicit market in a country in Europe, legislators need to choose whether to bring it under control of the drug laws, and for public health reasons they may need to do so quickly. A comparative study of...

Publications

Report on the risk assessment of BZP in the framework of the Council decision on new psychoactive substances

01.02.2009

This publication presents the findings of the formal risk assessment on BZP, produced in 2007 by the Scientific Committee of the EMCDDA, with participation of additional experts from the European Commission, Europol and the EMEA. The risk assessment report, which was submitted to the European...
Loading